Itraconazole is an antifungal medication used to treat a variety of fungal infections [1]. It is available in capsule form and is also administered intravenously [1].
What fungal infections does itraconazole treat?
Itraconazole is prescribed for infections such as blastomycosis, histoplasmosis, and aspergillosis [1]. It is also used for onychomycosis (fungal infection of the nails) and certain types of vaginal yeast infections (vulvovaginal candidiasis) [1]. Its use may be recommended for patients who cannot tolerate other antifungal treatments [1].
How does itraconazole work?
As a triazole antifungal agent, itraconazole works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes [1]. This disruption leads to increased fungal cell membrane permeability and ultimately cell death [1].
When does itraconazole's patent exclusivity expire?
The patent exclusivity for itraconazole has expired, allowing for the availability of generic versions [2]. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals [2].
Are there alternatives to itraconazole capsules?
Yes, several other antifungal medications are available. These include fluconazole, voriconazole, posaconazole, and amphotericin B, among others, each with different uses and potential side effects [3]. The choice of antifungal depends on the specific type of fungal infection, its severity, and the patient's medical history [3].